~~<i id='95F9698C1C'><strike id='95F9698C1C'><tt id='95F9698C1C'><pre id='95F9698C1C'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

explore

author：hotspot 2025-09-27 09:40:54 - browse：71268

Trump Campaign Event In Nevada — Ethan Miller/Getty Images

WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Why Novartis is changing the name of its research labs

focus

leisure time

focus

hotspot

0:04PeoplegatheraroundandcheerforKaiCenatasmembersoftheNYPDrespondtothousandsofpeoplegatheredfora"gi

WSS

2 US Navy sailors arrested for allegedly spying for China

Crinetics acromegaly drug succeeds in late

AstraZeneca chief proposes a novel edit to the drug pricing bill

Crinetics acromegaly drug succeeds in late

Medicaid rebukes states for mistakenly disenrolling children

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

hotspot

explore

focus

Wildfire smoke exposes gaps in outdoor worker protections

2 US Navy sailors arrested for allegedly spying for China

Drug repurposing or repositioning? The language matters

ALS advocates say criticism of new drugs misses bigger picture

Continuity nursing helped my family in our darkest PICU moments

Attacks on the drug industry will lead to fewer breakthroughs

In age of alternative facts, a scholarly course on calling out crap

ER docs worry over extreme heat as a 'mass casualty event'

BioMarin wins approval for gene therapy to treat hemophilia A

Biden calls for immediate release of Niger's president amid apparent coup

focus

For BCIs, commercial hurdles may be bigger than scientific ones

ER docs worry over extreme heat as a 'mass casualty event'

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

ProMED, early warning system on disease outbreaks, in peril

Attacks on the drug industry will lead to fewer breakthroughs

Microsoft strikes partnership with Duke Health to advance health AI

leisure time

focus

focus

hotspot